InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: Ubertino post# 70623

Wednesday, 08/07/2013 12:12:22 PM

Wednesday, August 07, 2013 12:12:22 PM

Post# of 146240
"...Unlike these existing drugs, however, NanoViricides’ technology acts before the virus has had a chance to gain entry into a healthy cell. This is like defeating a besieging enemy army with withering fire before it’s forced the city gates or undermined the defensive walls. The alternative methods used today are the equivalent of a last-ditch house-to-house battle after the defenses have been breached..." ~ Patrick Cox

Nanoviricides, Inc. is not about just any drug making platform. It is about THE BREAKTHROUGH bionanotechnology platform for antiviral drug delivery. Like "LEGO pieces" the polymeric anphiphilic micelles come together to become a virus most lethal enemy.

There are about 100 trillion cells in a human body and there are approximately 70 trillion "water-loving" polymeric micelles in one dose of DengueCide™. A couple of doses of these "non-toxic" and "water-loving" polymeric micelles is like posting a sentinel at every house, a sentinel with the defensive/offensive skills of a "terminator". ---
---

Nanoviricides, Inc. has had no failures in 5000 animal studies with FluCide™, "...and none are anticipated in humans because we are agnostic to the host...as long as you have a virus in your circulation, we destroy it..." Dr. Eugene Seymour, CEO Nanoviricides, Inc..

DengueCide™ is a developmental drug, a "terminator" in developmental stage, now with Orphan Drug designation.

How do I feel about NNVC? I think many of us here share the same sentiment. Confidence is very high! ---
- Woo-wooo!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News